BVF PARTNERS L P/IL - Director, Other* at Kymera Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Company
Role
Director, Other*
Issuer Symbol
KYMR on Nasdaq
All Insider Reports
All Insider Reports

BVF PARTNERS L P/IL - trading volume in the past year for Kymera Therapeutics, Inc.

Holdings reported by BVF PARTNERS L P/IL for Kymera Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock, $0.0001 par value 353,412 $15,550,128 $44.00 30 Jun 2025 Direct
Pre-Funded Warrants to Purchase Common Stock 52,733 $2,511,145 $47.62 25 Jun 2025 Direct Common Stock, $0.0001 par value 52,733
Stock Option (Right to Buy) 16,000 $761,920 $47.62 25 Jun 2025 Indirect Common Stock, $0.0001 par value 16,000

Transactions reported by BVF PARTNERS L P/IL for Kymera Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.